Literature DB >> 12004958

Sensitization and subjective health complaints.

Hege R Eriksen1, Holger Ursin.   

Abstract

Why is it that some of us have more pain, more fatigue, and more gastrointestinal trouble than others? Is it possible that there are brain mechanisms and psychological mechanisms that make some people sensitized to specific complaints? In this concluding paper we review the historical and theoretical background, discuss the evidence and theoretical positions in the contributions, and draw some conclusions. Traditional psychosomatic models had less predictive value and less therapeutic importance than what was hoped for. The main problem with these models was the lack of a pathophysiological explanation for why psychological problems could be related to somatic disease. Sustained arousal or "allostatic load" offers more plausible and acceptable mechanisms for pathology, and, to some extent, for sensitization and illness. The combination of cognitive psychology and neurophysiology offers a model for somatic pathology, and, perhaps more important, also for the understanding of subjective complaints and illness.

Entities:  

Mesh:

Year:  2002        PMID: 12004958     DOI: 10.1111/1467-9450.00286

Source DB:  PubMed          Journal:  Scand J Psychol        ISSN: 0036-5564


  24 in total

1.  Need for recovery from work related fatigue and its role in the development and prediction of subjective health complaints.

Authors:  J K Sluiter; E M de Croon; T F Meijman; M H W Frings-Dresen
Journal:  Occup Environ Med       Date:  2003-06       Impact factor: 4.402

2.  Modifying the implicit illness-related self-concept in patients with somatoform disorders may reduce somatic symptoms.

Authors:  Kathrin Riebel; Boris Egloff; Michael Witthöft
Journal:  Int J Behav Med       Date:  2014

Review 3.  Phenomena associated with sick leave among primary care patients with Medically Unexplained Physical Symptoms: a systematic review.

Authors:  Aase Aamland; Kirsti Malterud; Erik L Werner
Journal:  Scand J Prim Health Care       Date:  2012-07-21       Impact factor: 2.581

4.  Subjective health complaints and modern health worries in patients with subjective food hypersensitivity.

Authors:  Ragna Lind; Gülen Arslan; Hege R Eriksen; Gudrun Kahrs; Tone Tangen Haug; Erik Florvaag; Arnold Berstad
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

5.  Gray Matter Changes Following Cognitive Behavioral Therapy for Patients With Comorbid Fibromyalgia and Insomnia: A Pilot Study.

Authors:  Christina S McCrae; Jennifer M Mundt; Ashley F Curtis; Jason G Craggs; Andrew M O'Shea; Roland Staud; Richard B Berry; William M Perlstein; Michael E Robinson
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

6.  Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome.

Authors:  Michael E Robinson; Jason G Craggs; Donald D Price; William M Perlstein; Roland Staud
Journal:  J Pain       Date:  2010-12-13       Impact factor: 5.820

7.  Health care utilisation and attitudes towards health care in subjects reporting environmental annoyance from electricity and chemicals.

Authors:  Frida Eek; Juan Merlo; Ulf Gerdtham; Thor Lithman
Journal:  J Environ Public Health       Date:  2009-04-14

8.  Are subjective health complaints a result of modern civilization?

Authors:  Hege R Eriksen; Brit Hellesnes; Peer Staff; Holger Ursin
Journal:  Int J Behav Med       Date:  2004

9.  Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia Index.

Authors:  Gülen Arslan; Ragna Lind; Snorri Olafsson; Erik Florvaag; Arnold Berstad
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

10.  Similarities in stress physiology among patients with chronic pain and headache disorders: evidence for a common pathophysiological mechanism?

Authors:  Rune Bang Leistad; Kristian Bernhard Nilsen; Lars Jacob Stovner; Rolf Harald Westgaard; Magne Rø; Trond Sand
Journal:  J Headache Pain       Date:  2008-03-29       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.